, Volume 82, Issue 4, pp 301–305 | Cite as

Acute and long-term effects of thyrotropin releasing hormone on behavior mediated by dopaminergic and cholinergic activities in mice

  • Itsuko Ushijima
  • Katsushi Yamada
  • Tatsuo Furukawa
Original Investigations


Acute and long-term (3 weeks) effects of thyrotropin releasing hormone (TRH) on behavior were investigated in mice. A single injection of TRH produced Straub tail, tremor and salivation, as well as stereotyped responses, such as head bobbing, jaw movement, digging and sniffing. Dose- and time-dependency for the effects of TRH were different depending on each response. A single injection of TRH at a low dose of 2.5 mg/kg SC did not produce stereotypy but this behavior was induced when this dose of TRH was administered in combination with atropine (3 mg/kg IP). In addition, a single low dose of TRH elicited tremor and salivation which were potentiated by physostigmine (0.1 mg/kg IP). A single high dose (20 mg/kg IP) produced marked tremor and salivation which were conversely blocked by atropine. Following daily administration of TRH at a low dose of 2.5 mg/kg SC for 21 days, stereotyped behavior was progressively increased whereas tremor and salivation were decreased. This increase in stereotyped behavior was inhibited by haloperidol (1 mg/kg IP) or physostigmine (0.1 mg/kg IP). When saline was administered instead of TRH for 3 days after long-term administration of TRH, stereotyped behavior was maintained for 2 days but thereafter decreased to some extent. When TRH (1.25 mg/kg SC) was again administered at this stage, there was a marked increase in stereotyped response. These results suggest that TRH induces dopaminergic activation, accompanied by both cholinergic inhibition and cholinergic activation, and that the former is potentiated while the latter is reduced after daily administration of TRH.

Key words

Thyrotropin releasing hormone Acute effect Long-term effect Stereotypy Tremor Mice 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Agid Y, Guyenet P, Glowinski J, Beaujouan JC, Javoy F (1975) Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neruons in the rat. Brain Res 86:488–492Google Scholar
  2. Asher IM, Aghajanian GK (1974) 6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: Effect on amphetamine-induced stereotyped behavior in rats. Brain Res 82:1–12Google Scholar
  3. Breese GR, Cott JM, Cooper BR, Prange AJ Jr, Lipton MA, Plotnikoff NP (1975) Effects of thyrotropin-releasing hormone (TRH) on the action of pentobarbital and other centrally acting drugs. J Pharmacol Exp Ther 193:11–22Google Scholar
  4. Cools AR, Van Rossum JM (1970) Caudal dopamine and stereotyped behavior of cats. Arch Int Pharmacodyn Ther 187:163–173Google Scholar
  5. Costall B, Hui SCG, Matcalf G, Naylor RJ (1979) A study of the changes in motor behavior caused by TRH on intracerebral injection. Eur J Pharmacol 53:143–150Google Scholar
  6. de Belleroche J, Neal MJ (1982) The contrasting effects of neuroleptics on transmitter release from nucleus accumbens and corpus striatum. Neuropharmacology 21:529–537Google Scholar
  7. Ernst AM (1967) Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia 10:316–323Google Scholar
  8. Ervin GN, Schmitz SA, Nemeroff CB, Prange AJ Jr (1981) Thyrotropin-releasing hormone and amphetamine produce different patterns of behavioral excitation in rats. Eur J Pharmacol 72:35–43Google Scholar
  9. Groves PM, Wilson CJ, Young SJ, Rebec GV (1975) Self-inhibition by dopaminergic neurons: An alternative to the “neuronal feed back loop” hypothesis for the mode of action of certain psychotropic drugs. Science 190:522–529Google Scholar
  10. Heal DJ, Atterwill CK (1982) Repeated administration of triiodothyronine (T3) to rats enhances nigrostriatal and mesolimbic dopaminergic behavioral responses. Neuropharmacology 21:159–162Google Scholar
  11. Heal DJ, Green AR (1979) Administration of thyrotropin releasing hormone (TRH) to rats release dopamine in n. accumbens but not n. caudatus. Neuropharmacology 18:23–31Google Scholar
  12. Hökfelt T, Fuxe K, Johansson O, Jeffcoate S, White N (1975) Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur J Pharmacol 34:389–392Google Scholar
  13. Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OH DA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507–522Google Scholar
  14. Klawans HL, Goetz Ch Jr, Weiner WJ (1973) Dopamine receptor site sensitivity in hyperthyroid guinea pigs: A possible model of hyperthyroid chorea. J Neural Transm 34:187–193Google Scholar
  15. Klawans HL, Crossett P, Dana N (1975a) Effect of chronic amphetamine exposure on stereotyped behavior: Implications for the pathogenesis of l-Dopa-induced dyskinesias. In: Chalne BB, Chase TN, Barbeau A (eds) Advances in neurology, vol 9. Raven Press, New York, pp 105–112Google Scholar
  16. Klawans HL, Margolin DL, Dana N, Crossett P (1975b) Supersensitivity to d-amphetamine and apomorphine-induced stereotyped behavior induced by chronic d-amphetamine administration. J Neural Sci 25:283–289Google Scholar
  17. Marek K, Haubrich DR (1977) Thyrotropin-releasing hormone increased catabolism of catecholamines in brains of thyroidectomized rats. Biochem Pharmacol 26:1817–1818Google Scholar
  18. Miyamoto M, Nagawa Y (1977) Mesolimbic involvement in the locomotor stimulant action of thyrotropin-releasing hormone (TRH) in rats. Eur J Pharmacol 44:143–152Google Scholar
  19. Miyamoto M, Narumi S, Nagai Y, Shima T, Nagawa Y (1979) Phyrotropin-releasing hormone: Hyperactivity and mesolimbic dopamine system in rats. Jpn J Pharmacol 29:335–347Google Scholar
  20. Narumi S, Nagai Y, Nagawa Y (1979) Thyrotropin-releasing hormone (TRH): Action mechanism of an enhanced dopamine release from rat striatal slices. Folia Pharmacol Jpn 75: 239–250Google Scholar
  21. Rastogi RB, Singhal RL, Lapierre YD (1981) Effects of MK-771, a novel TRH analog, on brain dopaminergic and serotonergic systems. Eur J Pharmacol 73:307–312Google Scholar
  22. Roberts DCS, Zis AP, Fibiger HC (1975) Asending catecholamine pathways and amphetamine-induced locomotor activity: Importance of dopamine and apparent non-involvement of norepinephrine. Brain Res 93:441–454Google Scholar
  23. Robinson SE, Malthe-Sørenssen D, Wood PL, Commissiong J (1979) Dopaminergic control of the septal-hippocampal cholinergic pathway. J Pharmacol Exp Ther 208:476–479Google Scholar
  24. Roth RH, Bunney BS (1976) Interaction of cholinergic neurons with other chemically defined neuronal systems in the CNS. In: Goldberg AM, Hanin I (eds) Biology of cholinergic function. Raven, New York, pp 379–394Google Scholar
  25. Segal DS, Mandell AJ (1974) Long-term administration of d-amphetamine: Progressive augmentation of motor-activity and stereotypy. Pharmacol Biochem Behav 2:249–255Google Scholar
  26. Siegel S (1956) Nonparametric statistics for the behavioral sciences. McGraw-Hill, Tokyo, p 96Google Scholar
  27. Spindel ER, Pettibone DJ, Wurtman RJ (1981) Thyrotropin-releasing hormone (TRH) content of rat striatum: Modification by drugs and lesions. Brain Res 216:323–331Google Scholar
  28. Taylor RL, Burt DR (1982) Species differences in the brain regional distribution of receptor binding for thyrotropin-releasing hormone. J Neurochem 38:1649–1656Google Scholar
  29. Trabucchi M, Cheney GL, Racagni G, Costa E (1975) In vivo inhibition of striatal acetylcholine turnover by l-Dopa, apomorphine and (+)-amphetamine. Brain Res 85:130–134Google Scholar
  30. Ushijima I, Yamada K, Furukawa T, Noda Y, Todoroki M, Inanaga K (1980) Biphasic effects of thyrotropin-releasing hormone on exploratory behavior in mice. Arch Int Pharmacodyn Ther 247:257–263Google Scholar
  31. Wei E, Sigel S, Loh H, Way EL (1975) Thyrotropin-releasing hormone and shaking behavior in rat. Nature 253:739–740Google Scholar
  32. Yamada K, Furukawa T (1980) Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacology 67:39–43Google Scholar
  33. Yamada K, Matsuki J, Ushijima L, Inoue T, Purukawa T (1983) Behavioral studies of shaking behavior induced by thyrotropin-releasing hormone and morphine withdrawal in rats. Arch Int Pharmacodyn Ther 262:24–33Google Scholar
  34. Yarbrough GG (1978) Studies on the neuropharmacology of thyrotropin-releasing hormone (TRH) and a new TRH analog. Eur J Pharmacol 48:19–27Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • Itsuko Ushijima
    • 1
  • Katsushi Yamada
    • 1
  • Tatsuo Furukawa
    • 1
  1. 1.Department of Pharmacology, School of MedicineFukuoka UniversityFukuokaJapan

Personalised recommendations